AI-generated summary
The authors report on 76 patients with melasma that had not cleared with triple-combination cream alone, who were treated with a fractional 1540-nm erbium-glass laser plus the cream. At 1 month, marked or moderate clearing was reported in most patients, but at 6 months only 21.1% showed marked improvement and 43.4% showed none. The authors describe the long-term benefit as limited.
- Participants
- 76
- Who or what was studied
- Patients with melasma resistant to triple-combination cream alone
- Wavelengths
- 1540 nm
- Limits stated in the abstract
- The abstract does not describe a control group and reports only the single-arm results of this treatment protocol.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.